Search results
Results From The WOW.Com Content Network
The name "cannabinoid hyperemesis syndrome" was also coined at this time. The report focused on nine patients who were chronic cannabis users who presented with cyclical vomiting illness. One woman in the study reported that warm baths provided the only relief from the nausea, severe vomiting, and stomach pain, and reportedly burned herself in ...
Aprepitant has been identified as having strong potential in treating protracted vomiting episodes in individuals with cannabinoid hyperemesis syndrome. [25] This syndrome is characterized by nausea , cyclical vomiting , and cramping abdominal pain resulting from prolonged, frequent cannabis use.
Long term cannabis users are at risk for developing cannabinoid hyperemesis syndrome (CHS), characterized by recurrent bouts of intense vomiting. The mechanism behind CHS is poorly understood and is contrary to the antiemetic properties of cannabis and cannabinoids. [73]
Long-term cannabis users are at risk for developing cannabinoid hyperemesis syndrome (CHS), characterized by recurrent bouts of intense vomiting and abdominal cramping during or within 48 hours of heavy cannabis use. [112] The mechanism behind CHS is poorly understood and is contrary to the antiemetic properties of cannabis and cannabinoids.
For premium support please call: 800-290-4726 more ways to reach us
Cannabinoid medication might be useful in the treatment of the symptoms in patients with TS, [42] but the 2009 review found that the two relevant studies of cannabinoids in treating tics had attrition bias, and that there was "not enough evidence to support the use of cannabinoids in treating tics [or] obsessive [and] compulsive behaviour[s] in ...
Chronic usage of THC may result in cannabinoid hyperemesis syndrome (CHS), a condition characterized by cyclic nausea, ... distribution, clinical research, and ...
About the International Cannabinoid Research Society The International Cannabinoid Research Society (ICRS) is the premier global scientific association with more than 650 international members from 40 countries, all active researchers in the field of endogenous, plant-derived, and synthetic cannabinoids and related bioactive lipids. In addition ...